Huang Zhao-Bo, Wang Long, Kang Yao, Wang Tuan-Jie, Wang Zhen-Zhong, Zhang Hong-da, Bai Gang, Li Zheng, Li Wen-Long
College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine Tianjin 300193, China.
Jiangsu Kanion Pharmaceutical Co., Ltd. Lianyungang 222001, China State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process Lianyungang 222001, China.
Zhongguo Zhong Yao Za Zhi. 2022 Oct;47(19):5256-5263. doi: 10.19540/j.cnki.cjcmm.20220127.301.
Because of the complex components, simple content determination can hardly reflect the overall quality of Guizhi Fuling Capsules. Therefore, it is necessary to carry out a multi-component dissolution test. The variability of quality among different batches of products from different manufacturers is a common problem of Chinese medicine solid preparations. To comprehensively control the quality of Guizhi Fuling Capsules, we studied the dissolution behaviors of 7 index components in the capsules under different conditions, and investigated the consistency of dissolution behaviors among different batches of products from the same manufacturer. The basket method of general rule 0931 in Chinese Pharmacopoeia was adopted, and the rotating speeds were set at 50, 75, and 100 r·min~(-1), respectively. The hydrochloric acid solution(pH 1.2), acetate buffer solution(pH 4.0), pure water, and phosphate buffer solution(pH 6.8) were used as the dissolution media. Automatic sampling was carried out at the time points of 5, 10, 20, 30, 45, and 60 min, respectively. The cumulative dissolution of 7 index components was measured through ultra-performance liquid chromatography(UPLC). The difference factor f_1 and similarity factor f_2 were calculated to comprehensively evaluate the similarity of the dissolution curves among 8 batches of Guizhi Fuling Capsules, and a variety of dissolution and release equations were fitted. The results showed that multiple components had faster dissolution rates at higher rotating speed and in hydrochloric acid medium. The 8 batches of Guizhi Fuling capsules showed the average f_1 value lower than 15 and the average f_2 value higher than 50, which indicated that different batches of products had similar dissolution behaviors. Most components had synchronous dissolution behaviors and similar release cha-racteristics. This study provides a reference for the quality consistency evaluation among batches, processing optimization, and dosage form improvement of Guizhi Fuling Capsules.
由于成分复杂,单纯的含量测定难以反映桂枝茯苓胶囊的整体质量。因此,有必要进行多成分溶出度试验。不同厂家不同批次产品质量的变异性是中药固体制剂的常见问题。为全面控制桂枝茯苓胶囊的质量,我们研究了该胶囊中7种指标成分在不同条件下的溶出行为,并考察了同一厂家不同批次产品溶出行为的一致性。采用《中国药典》通则0931的篮法,转速分别设定为50、75和100 r·min⁻¹。以盐酸溶液(pH 1.2)、醋酸盐缓冲溶液(pH 4.0)、纯水和磷酸盐缓冲溶液(pH 6.8)作为溶出介质。分别在5、10、20、30、45和60分钟时间点进行自动取样。通过超高效液相色谱法(UPLC)测定7种指标成分的累积溶出量。计算差异因子f₁和相似因子f₂,以综合评价8批次桂枝茯苓胶囊溶出曲线的相似性,并拟合多种溶出和释放方程。结果表明,多种成分在较高转速和盐酸介质中溶出速度较快。8批次桂枝茯苓胶囊的平均f₁值低于15,平均f₂值高于50,表明不同批次产品具有相似的溶出行为。多数成分具有同步溶出行为和相似的释放特征。本研究为桂枝茯苓胶囊的批次间质量一致性评价、工艺优化和剂型改进提供了参考。